Ken‐Hong Lim

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Ayalew Tefferi, Animesh Pardanani, Ken‐Hong Lim et al. · Leukemia · 2009 · 418 citations · Full text

Hematological Malignancy, Polycythemia Vera, Bone Marrow Failure +10

Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

Ayalew Tefferi, Ross L. Levine, Ken‐Hong Lim et al. · Leukemia · 2009 · 243 citations · Full text

Mast Cell Disorder, Systemic Mastocytosis, Frequent Tet2 Mutations +6

The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement

Laure Gossec, S. Paternotte, J.F. Maillefert et al. · Osteoarthritis and Cartilage · 2010 · 193 citations · Full text

International Cross-sectional Study, Hip Arthroplasty, Chronic Musculoskeletal Condition +12

Female Sex and Bronchioloalveolar Pathologic Subtype Predict EGFR Mutations in Non-small Cell Lung Cancer

Ruey-Kuen Hsieh, Ken‐Hong Lim, Hsu-Tah Kuo et al. · CHEST Journal · 2005 · 125 citations

Tumor Biology, Female Sex, Pathology +7

NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia

Ming‐Chin Chang, Hung-I Cheng, Kate Hsu et al. · Frontiers in Immunology · 2019 · 48 citations · Full text